- Home
- NINE vs ANTX Comparison
NINE vs ANTX Comparison
Compare NINE & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- ANTX
- Stock Information
- Founded
- NINE 2011
- ANTX 2017
- Country
- NINE United States
- ANTX United States
- Employees
- NINE N/A
- ANTX N/A
- Industry
- NINE Oilfield Services/Equipment
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- NINE Energy
- ANTX Health Care
- Exchange
- NINE Nasdaq
- ANTX Nasdaq
- Market Cap
- NINE 29.8M
- ANTX 31.4M
- IPO Year
- NINE 2018
- ANTX 2022
- Fundamental
- Price
- NINE $0.66
- ANTX $1.26
- Analyst Decision
- NINE
- ANTX Buy
- Analyst Count
- NINE 0
- ANTX 2
- Target Price
- NINE N/A
- ANTX $2.00
- AVG Volume (30 Days)
- NINE 706.6K
- ANTX 90.0K
- Earning Date
- NINE 10-30-2025
- ANTX 08-12-2025
- Dividend Yield
- NINE N/A
- ANTX N/A
- EPS Growth
- NINE N/A
- ANTX N/A
- EPS
- NINE N/A
- ANTX N/A
- Revenue
- NINE $577,300,000.00
- ANTX N/A
- Revenue This Year
- NINE $4.56
- ANTX N/A
- Revenue Next Year
- NINE $1.41
- ANTX N/A
- P/E Ratio
- NINE N/A
- ANTX N/A
- Revenue Growth
- NINE 3.23
- ANTX N/A
- 52 Week Low
- NINE $0.44
- ANTX $0.98
- 52 Week High
- NINE $1.87
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- NINE 48.29
- ANTX 67.15
- Support Level
- NINE $0.64
- ANTX $1.09
- Resistance Level
- NINE $0.70
- ANTX $1.29
- Average True Range (ATR)
- NINE 0.05
- ANTX 0.07
- MACD
- NINE 0.01
- ANTX 0.02
- Stochastic Oscillator
- NINE 64.78
- ANTX 85.71
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.